Hospira Gemcitabine for IV Infusion 200 mg

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

gemcitabine hydrochloride, Quantity: 45.54 mg/mL

Commercializzato da:

Hospira Australia Pty Ltd

INN (Nome Internazionale):

Gemcitabine hydrochloride

Forma farmaceutica:

Injection, intravenous infusion

Composizione:

Excipient Ingredients: mannitol; sodium acetate trihydrate

Via di somministrazione:

Intravenous Infusion

Confezione:

1 X 10 mL vial

Classe:

Medicine Listed (Export Only)

Tipo di ricetta:

(S1) This Schedule is intentionally blank

Indicazioni terapeutiche:

Non-small cell lung cancer, pancreatic cancer, biliary tract cancer, uroepithelial cancer, inoperable or recurrent breast cancer, ovarian cancer progressing after chemotherapy.

Dettagli prodotto:

Visual Identification: A white to off white lyophilized powder in a clear glass vial; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Listed (Export Only)

Data dell'autorizzazione:

2013-01-07